Depression Clinical Trial
Official title:
Perinatal Stress and Gene Influences: Pathways to Infant Vulnerability
This study will evaluate pregnant women with a past or current diagnosis of depression or anxiety to gain a better understanding of how these disorders can affect an infant's development, both during and after pregnancy.
Depression and anxiety are serious conditions affecting millions of people each year. In
fact, it is estimated that approximately one in every four women will be treated for a mood
disorder, such as depression or anxiety, at some point in her life. As effective treatment
options continue to develop, many women diagnosed with depression or anxiety are able to
resume normal lives and may choose to become pregnant. However, studies suggest that the
intrauterine environment can be altered by maternal stress, depression, and anxiety, which
may affect the fetus during pregnancy. Also, antidepressant medications have been known to
cause complications for both the mother and fetus, which can make pregnancy a very difficult
time for women with a history of depression and anxiety. These women are more prone to
relapse during pregnancy, even if they previously recovered from the disorder. The purpose
of this study is to evaluate whether symptoms of depression and anxiety, during or soon
after pregnancy, affect an infant's social and emotional development.
Participation in this study will occur from early in the woman's pregnancy until her
infant's first birthday. Participants will attend at least eight study visits during
pregnancy and five study visits during the first year of the infant's life. Most study
visits will take place at the Emory University clinic on campus. During the first study
visit, participants will complete questionnaires regarding their current mood, stressors,
supports, experiences during pregnancy, symptoms of depression or anxiety, and any treatment
or medications they are currently receiving. Urine and blood will also be collected at the
initial visit. Follow-up visits, lasting 1 hour, will occur monthly until delivery. During
these visits, similar questionnaires will be administered and blood, urine, and saliva
samples will be collected. Uterine blood flow, fetal activity, and fetal heart rate will be
recorded at some follow-up visits. Women who undergo an amniocentesis will have the option
of providing a sample of amniotic fluid and an additional blood sample.
Immediately after delivery, blood from the baby's umbilical cord and blood from the mother
will be collected. A week after delivery, a home visit will be scheduled to assess each
mother's mood, stress, supports, delivery complications, and first impressions of the new
baby. At this time, a behavioral assessment will also be conducted on each infant, and
mothers will be observed while interacting with their child. At the infant's 6-month
pediatrician visit, a saliva sample will be taken to measure levels of cortisol and other
indicators of stress. Infants will be assessed at three other times before their first
birthday. During these assessments, the infant's ability to regulate his or her emotions
will be evaluated by videotaped behavioral observations, stress hormones from saliva, heart
rate, or recordings of brain activity through the use of either an electroencephalogram
(EEG) or event related potentials (ERP). Lastly, participants will be given the option to
provide a DNA sample for further analysis and future research. Fathers of the babies will be
included in selected study visits. Results from this study will be used to help prevent
emotional and social developmental problems in infants whose mothers have been diagnosed
with either depression or anxiety.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A |